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PHARMACODYNAMICS	  MINER:	  AN	  AUTOMATED	  EXTRACTION	  OF	  
PHARMACODYNAMIC	  DRUG	  INTERACTIONS	  Pharmacodynamics	   (PD)	   studies	   the	   relationship	  between	  drug	   concentration	  and	  drug	  effect	  on	  target	  sites.	  This	  field	  has	  recently	  gained	  attention	  as	  studies	  involving	  PD	  Drug-­‐Drug	   interactions	   (DDI)	   assure	   discovery	   of	   multi-­‐targeted	   drug	   agents	   and	   novel	  efficacious	   drug	   combinations.	   A	   PD	   drug	   combination	   could	   be	   synergistic,	   additive	   or	  antagonistic	  depending	  upon	   the	   summed	  effect	  of	   the	  drug	  combination	  at	   a	   target	   site.	  The	   PD	   literature	   has	   grown	   immensely	   and	   most	   of	   its	   knowledge	   is	   dispersed	   across	  different	  scientific	  journals,	  thus	  the	  manual	  identification	  of	  PD	  DDI	  is	  a	  challenge.	  In	  order	  to	  support	  an	  automated	  means	  to	  extract	  PD	  DDI	  we	  propose	  Pharmacodynamics	  Miner	  (PD-­‐Miner).	  	  PD-­‐Miner	  is	  a	  text-­‐miningtool,	  which	  is	  capable	  of	  identifying	  PD	  DDI	  from	  in	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“Pharmacogenetics	   (PG)	   is	   defined	   as	   the	   study	   of	   inherited	   variations	   in	   drug	  responses	   and	  metabolism.”	  The	   term	   is	   derived	   from	   ‘Pharmacology’,	  which	   studies	   the	  mechanism	   of	   drug	   in	   the	   body,	   while	   ‘Genetics’	   takes	   into	   account	   hereditary	   and	  variations	   of	   the	   inherited	   characteristics.	   PG	   is	   highly	   valuable,	   especially	   for	   clinical	  studies,	  it	  uncovers	  an	  individual’s	  drug	  response	  and	  possible	  drug	  side	  effects	  based	  upon	  the	  genetic	  makeup.	  This	  knowledge	   is	   important	   to	  assist	   thedevelopment	  of	  new	  drugs	  suitable	   for	   an	   individual	   (Personalized	   medicine)	   or	   to	   a	   particular	   group.	   Apart	   from	  being	  a	  key	  to	  personalized	  medicine,	  PG	  offers	  the	  following	  potential	  advantages.	  	  





3. Safer	  doses:	  Knowledge	  of	  genomic	  variation	  would	  enhance	  the	  determination	  of	  accurate	  drug	  dosages,	  thus	  decreasing	  the	  adverse	  effect	  that	  might	  arise	  due	  to	  traditional	  trial	  and	  error	  methods.	  	  
Genetic	   variability	   is	   crucial	   and	   can	   affect	   pharmacokinetics	   and	  pharmacodynamics	  of	  drug	  metabolism.	  “Pharmacokinetics	  (PK)	  is	  deﬁned	  as	  the	  study	  of	  the	   time	   course	   of	   drug	   absorption,	   distribution,	   metabolism,	   and	   excretion	   (ADME)”.	  Clinical	   PK	   is	   the	   study	   of	   the	   relationships	   between	   drug	   dosage	   regimens	   and	  concentration–time	  profiles	   [1].Clinical	  pharmacokinetics	  primarily	   focuses	  on	  enhancing	  the	   drug	   efficacy,	   while	   reducing	   the	   toxicity	   of	   patient’s	   drug	   therapy.	  “Pharmacodynamics	  (PD)	  refers	  to	  the	  study	  of	  relationship	  between	  drug	  concentration	  at	  the	  target	  site,	  the	  resulting	  effect	  along	  with	  the	  time	  course,	  and	  adverse	  effect”.	   	  The	  effect	  is	  usually	  measured	  by	  analyzing	  the	  drug	  binding	  receptors;	  binding	  receptor	  could	  be	   anything	   neurons	   in	   the	   central	   nervous	   systems	   or	   cardiac	   muscles	   to	   control	   the	  intensity	  of	  heart	  contraction.	  	  







One	   of	   the	   many	   challenges	   in	   drug	   development	   and	   drug	   administration	   is	  accurate	  identification	  of	  drug	  interactions.	  The	  problem	  of	  drug	  interactions	  arises	  when	  multiple	  drugs	  are	  administrated	   together,	  causing	   increase	  or	  decrease	   in	   the	  activity	  of	  one	   drug	   by	   the	   other	   drug	   or	   drugs.	   A	   Drug	   interaction	   can	   be	   as	   defined	   as	   a	  pharmacological	  or	  clinical	   response	   to	   the	  administration	  or	  co-­‐exposure	  of	  a	  drug	  with	  another	  substance	   that	  modifies	   the	  patient’s	   response	   to	   the	  drug	   [2].	  Drug	   interactions	  especially	  adverse	  drug	  interactions	  are	  responsible	  for	  almost	  5%	  of	  hospitalization	  in	  the	  United	  States,	  it	  is	  estimated	  that	  the	  total	  cost	  associated	  with	  each	  hospitalization	  is	  more	  than	  $16000.	  With	  the	  development	  of	  new	  drug	  the	  chances	  of	  adverse	  drug	  interactions	  grows	  exponentially	  as	  each	  new	  drug	  is	  added	  to	  an	  individual’s	  regime	  [3].	  The	  chances	  of	  adverse	  drug	  reactions	  are	  more	  in	  elderly	  population	  and	  in	  patients	  who	  consume	  for	  than	   one	   drug	   at	   a	   time.	   There	   are	   evidences,	   which	   suggest	   that,	   a	   clinical	   drug	  interactions	   ranges	   from	   3	   to	   5%	   in	   patients	   with	   few	   medications,	   but	   it	   increases	  drastically	   to	   20%	   in	   patients	   consuming	   10–20	   drugs.	   Adverse	   drug	   interaction	   are	  complex	   events	   and	   are	   broadly	   divided	   into	   pharmacokinetic	   and	   pharmacodynamics	  drug	  interactions.	  	  





of	   a	   drug	   combination	   PD-­‐DDI	   is	   divided	   into	   synergistic,	   additive,	   and	   antagonistic	  categories.	  	  	  
SYNERGISTIC	  DRUG	  INTERACTION	  
The	   National	   Cancer	   Institute	   (NCI)	   defines	   synergistic	   drug	   interaction	   as	   the	  interaction	  of	  two	  or	  more	  drugs	  when	  their	  combined	  effect	  is	  greater	  than	  the	  sum	  of	  the	  effects	  seen	  when	  each	  drug	  is	  given	  alone	  [4].	  Equation	  wise	  synergistic	  drug	  interaction	  could	  be	  represented	  as	  1(Drug	  A)	  +	  1(Drug	  B)	  =	  3.	  A	  beneficial	   synergistic	  effect	  occurs	  when	  two	  different	  types	  of	  antibiotics	  that	  work	  in	  different	  ways	  are	  combined,	  such	  as	  penicillin-­‐G	   and	   aminoglycoside	   antibiotic.	   	   This	   approach	   is	   used	   to	   cure	   sub-­‐acute	  endocarditis.	   A	   harmful	   synergistic	   effect	   could	   be	   represented	   by	   interactions	   between	  drugs	   that	   depress	   the	   CNS,	   such	   as	   morphine	   and	   alcohol;	   this	   interaction	   causes	  additional	  CNS	  depression	  that	  could	  be	  fatal.	  
ANTAGONISTIC	  DRUG	  INTERACTION	  
	   Antagonistic	  effect	   is	   the	  opposite	  of	  a	  synergistic	  effect.	   It	  results	   in	  a	  therapeutic	  effect	   that	   is	   less	   than	   the	   effect	   of	   either	   drug	   alone	   because	   the	   second	   drug	   either	  diminishes	   or	   cancels	   the	   effect	   of	   the	   first	   drug.	   As	   an	   equation,	   this	   concept	   could	   be	  represented	   as	   1(Drug	   A)	   +	   1(Drug	   B)	   =	   0.	   	   For	   example,	   when	   the	   heparin	   antagonist	  protamine	   sulfate	   (A	   strong	   basic	   anticoagulant)	   is	   given	   as	   an	   antidote	   for	   heparin	   (A	  strong	  acidic	  anticoagulant)	  to	  halt	  heparin-­‐induced	  bleeding,	  a	  stable	  salt	  forms,	  resulting	  in	  loss	  of	  anticoagulant	  activity	  for	  both	  drugs.	  





ADDITIVE	  DRUG	  INTERACTIONS	  
An	   additive	   effect	   occurs	   when	   two	   or	   more	   drugs	   (in	   terms	   of	   therapeutic	   effect)	   are	  combined	  and	   the	  result	   is	   sum	  of	   the	  drug	  effect.	  Equation	  wise	  additive	  effect	  could	  be	  represented	  as	  1(Drug	  A)	  +	  1(Drug	  B)	  =	  2.	  Codeine	  and	  acetaminophen	  work	  differentially	  to	  reduce	  pain.	  When	  these	  two	  analgesic	  drugs	  are	  combined,	  the	  additive	  effect	  is	  better	  control	  of	  pain	  (compared	  with	  that	  resulting	  from	  the	  use	  of	  either	  drug	  alone).	  
TEXT	  MINING	  	  	  Text	   mining	   can	   be	   defined	   as	   an	   automated	   or	   semi-­‐automated	   means	   for	  exploiting	   and	   analyzing	  huge	   sets	   of	   textual	   data	   to	   discover	   knowledge.	   Text	  mining	   is	  different	  from	  data	  mining	  as	  data	  mining	  takes	  into	  account	  structured	  data	  usually	  data	  from	   databases,	   while	   text	   mining	   works	   on	   unstructured	   data	   for	   example	   data	   from	  websites	  or	  scientific	  articles.	  Today,	  almost	  all-­‐available	  information	  is	  stored	  in	  the	  form	  of	   text	   and	   hence	   text	  mining	   has	  more	   commercial	   and	   scientific	   application	   than	   data	  mining.	   Text	   mining	   is	   a	   complex	   science	   since	   most	   of	   the	   inherited	   information	   is	  unstructured	   and	   unclear,	   hence	   different	   linguistic	   algorithms	   are	   required	   before	  performing	   actual	   analysis.	   Text	   mining	   is	   interdisciplinary	   and	   covers	   information	  retrieval,	   information	   extraction,	   clustering,	   web	   mining	   etc.	   Information	   retrieval	   and	  information	  extraction	  are	  the	  two	  disciplines	  that	  are	  mostly	  applied	  on	  biological	  data.	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used	  to	  facilitate	  retrieval	  of	  relevant	   information	  from	  both	  structured	  and	  unstructured	  (textual)	  databases.	  Web	  based	  information	  retrieval	  engines	  like	  Google	  and	  PubMed	  are	  widely	  used	  to	  access	  up	  to	  date	  technical	  and	  scientific	  information.	  Information	  retrieval	  systems	  allow	  quick	  retrieval	  of	  relevant	  documents,	  more	  search	  flexibility	  using	  Boolean	  operators	  and	  ranking	  based	  on	  relevance	  of	  the	  documents.	  
INFORMATION	  EXTRACTION	  
Information	  extraction	  is	  a	  science	  that	  deals	  with	  automated	  extraction	  of	  entities,	  relationships	   between	   entities	   and	   attributes	   that	   could	   well	   describe	   entities	   from	  unstructured	  data	  repositories	  [5].	  More	  precisely,	  information	  extraction	  is	  a	  science	  that	  derives	   structured	   factual	   information	   from	   text.	   It	   is	   tougher	   than	   regular	   keyword	  searches	   and	   requires	   knowledge	   and	   understanding	   of	   sub-­‐fields	   like	   natural	   language	  processing,	   named	   entity	   recognition	   and	   shallow	   linguistics	   to	   extract	   meaning	   full	  relationships.	  	  
MEASURES	  DETERMINING	  ACCURACY	  





1.2	  OBJECTIVES	  AND	  CONTRIBUTION	  
	   The	   PD	   literature	   has	   grown	   enormously	   over	   the	   years,	   but	   is	   dispersed	   across	  many	   journals.	   Thus,	   it	   is	   challenging	   to	   identify	   important	   PD	   parameters	   and	   their	  associations.	   Drug	   dosage	   plays	   a	   key	   role	   in	   most	   PD	   based	   studies,	   identification	   of	  optimal	  drug	  dosages	  is	  important	  for	  clinical	  applications	  of	  the	  drug.	  Drug	  interaction	  is	  another	  PD	  parameter	  whose	   identification	   is	  crucial	   to	  avoid	  adverse	  drug	  reactions	  [6].	  Most	   PD	   information	   is	   present	   in	   descriptive	   full	   texts	   rather	   than	   in	   abstracts.	  Manual	  investigation	   of	   this	   information	   fromscientific	   article	   is	   slow	   and	   expensive	   and	   also	  depends	  upon	  the	  availability	  of	  full	  text	  to	  the	  researchers.	  Thus	  in	  order	  to	  avoid	  manual	  data	   investigation	  and	   to	   facilitate	  automated	  data	  retrieval,	   text	  mining	  system	  could	  be	  applied	  to	  PD	  domain.	  	  





proposes	  a	  drug	  dictionary	  to	  capture	  available	  generic	  names,	  synonym,	  and	  brand	  names	  of	  the	  drugs.	  
The	   system	   processes	   full	   text	   articles	   and	   abstracts	   in	   which	   sentences	   are	   first	  split	   individually	   and	   then	   terms	   are	   tokenized	   to	   form	   individual	   units.	   The	   tokenized	  terms	   are	   annotated	   following	   entries	   from	   both	   the	   drug	   dictionary	   and	   the	   in	   vitroPD	  ontology.	   Term	   annotation	   with	   ontology	   and	   drug	   dictionary	   allows	   formulation	   of	  semantic	  queries,	  thereby	  increasing	  the	  precision	  and	  recall	  of	  the	  system.	  The	  thesis	  also	  presents	   a	   semantically	   annotated	   corpus	   to	   serve	   as	   a	   gold	   standard	   for	   future	   PD	   text	  mining.	  	  
The	  contribution	  of	  this	  thesis	  is	  threefold:	  	  








Chapter	   2	   discusses	   the	   related	   work	   that	   covers	   other	   text	   mining	   system,	   existing	  ontologies,	  and	  drug	  repository.	  Development	  of	  the	  in	  vitro	  PD	  ontology	  is	  the	  backbone	  of	  the	   TM	   system	   and	   the	   annotated	   corpus,	   chapter	   3	   presents	   the	   data	   collection,	   data	  integration,	  and	  data	  processing	  for	  the	  ontology.	  Chapter	  4	  depicts	  the	  steps	  required	  for	  developing	   the	   database	   of	   annotated	   full	   text	   corpus	   and	   algorithms	   used	   for	   entity	  recognition.	  Chapter	  5	  describes	  the	  procedure	   for	  development	  of	   the	  annotated	  corpus.	  Chapter	  6	  presents	  an	  overview	  ofthe	  web	  tool.	  The	  validation	  and	  evaluation	  of	  the	  system	  is	  described	   in	   chapter	  7,	  while	   chapter	  8	   concludes	   the	   thesis	   and	  proposes	  outlook	   for	  future	  extension	  and	  improvements.	  	  	  
	  
	  







	  	   In	   this	   chapter,	   we	   present	   the	   current	   state-­‐of-­‐the-­‐art	   and	   provide	   overview	   of	  current	   Drug	   repositories,	   biological	   TMsystems,	   and	   bio-­‐ontologies.	   Finally	   we	   explain	  how	  the	  knowledge	  and	   information	   from	  these	  Drug	  repositories,	  TM	  system	  ontologies	  was	   gathered	   to	   develop	   new	   in	   vitro	   pharmacodynamics	   ontology	   and	   an	   information	  retrieval/extraction	  system.	  	  	  
2.1	  BIOLOGICAL	  INFORMATION	  RETRIEVAL	  AND	  EXTRACTION	  SYSTEMS	  	  
Information	   retrieval	   is	   a	   science	   responsible	   for	   retrieving	   a	   pertinent	   subset	   of	  documents	  from	  pool	  of	  other	  documents.	  Today,	  the	  best-­‐known	  biomedical	  IR	  system	  is	  PubMed;	   this	   IR	   functions	  with	  Boolean	   operators,	   vector	   space	  model	   and	  MeSH	   terms.	  The	  Boolean	  logic	  allow	  users	  to	  retrieve	  relevant	  documents	  using	  Boolean	  operator	  like	  ‘AND’,	  ‘OR’,	   ‘NOT’,	  using	  Boolean	  model	  the	  search	  is	  more	  customized	  to	  get	  user	  desired	  results.	  	  While	  use	  of	  Vector	  space	  model	  and	  MeSH	  terms	  assist	  the	  scoring	  and	  indexing	  of	  all	   terms	   in	   PubMed	   documents	   respectively.	   Literature	   databases	   like	   PubMed	   only	  contain	  bibliographic	   information	  and	  abstracts.	  They	  often	   suffer	   from	   the	   constraint	  of	  information	  compression	  and	  convolution	  imposed	  by	  a	  word	  limit.	  Thus,	  access	  to	  the	  full	  text	  articles	   is	  critical	   for	  sufficient	  coverage	  of	   facts	  and	  knowledge	   in	  the	   literature	  and	  for	   their	   retrieval	   [7].	   	   The	   section	   below	   discusses	   two	   full	   text	   information	  retrieval/extraction	  systems.	  	  





2.1.1	  TEXTPRESSO	  	  
Textpresso	   [8]	   is	   a	  new	   text	  mining	   system	  whose	   capabilities	   are	   far	  beyond	   the	  regular	  keyword	  based	  search	  systems.	  Textpresso	  [8]	  is	  powered	  by	  two	  major	  elements	  viz.	  collection	  of	  full	  text	  articles,	  which	  are	  split	  into	  individual	  sentences,	  and	  presence	  of	  33	   categories	   of	   terms	   in	   the	   form	   of	   ontology.	   The	   ontology	   categories	   include	   classes	  describing	  biological	  concepts	  e.g.	  gene,	  allele,	  phenotypes	  etc.	  and	  classes	  that	  relate	  two	  objects	  e.g.	  association,	  regulation	  etc.	  Individual	  terms	  from	  the	  text	  corpus	  are	  annotated	  with	   specific	  XML	   tags	   referencing	   the	   entries	   from	   the	   classes	  of	   the	  ontology.	  A	   search	  engine	   is	   built	   upon	   the	   annotated	   corpus,	   which	   can	   be	   queried	   using	   combination	   of	  keywords	  and	  categories,	  as	  the	  ontology	  covers	  term	  meanings	  it	  is	  possible	  to	  formulate	  semantic	  queries.	  Access	  to	  full	  text	  and	  presence	  of	  ontology	  is	  responsible	  for	  improved	  precision	   and	   recall	   of	   the	   system.	   Textpresso	   [8]	   is	   built	   using	   Caenorhabditiselegans	  literature	  with	  an	  article	  size	  of	  3,800	  full	  texts	  and	  16,000	  abstracts,	   it	  also	  comprises	  of	  around	  14,500	  entries	  from	  the	  ontology.	  Textpresso	  [8]	  is	  now	  used	  a	  curation	  tool	  and	  a	  search	  engine	  for	  researchers,	  it	  is	  also	  extended	  to	  other	  organism-­‐specific	  corpora	  of	  text.	  Textpresso	  [8]	  can	  be	  accessed	  www.textpresso.org.	  	  
2.1.2	  PHARMSPRESSO	  





evergrowingpharmacogenomics	   literature	   wealth,	   pharmspresso	   [9]	   was	   developed.	  Pharmspresso	   [9]	   has	   the	   ability	   to	   parse	   text	   to	   find	   references	   to	   human	   genes,	  polymorphism,	  drugs	  and	  disease	  and	  their	  relationship	  (Yael	  Garten	  et	  al	  2008).	  Just	  like	  textpresso	   [8],	   pharmspresso	   [9]	   involves	   the	   use	   of	   full-­‐text	   articles	   and	   ontology	   and	  hence	   it	   is	   capable	   of	   formulating	   sematic	   queries.	   Currently,	   pharmspresso	   [9]	   is	   an	  important	   curation	   tool	   for	   researchers	   in	   the	   field	   of	   pharmacogenomics	   and	   in	   many	  cases	  has	  helped	  in	  validating	  results	   from	  literature.	  Pharmspresso	  [9]	   is	  a	   free	  tool	  and	  can	  be	  downloaded	  from	  http://pharmspresso.stanford.edu.	  	  
	   Other	   than	   textpresso	   [8]	  and	  pharmspresso	   [9]	  other	   text	  mining	   tools	  also	  offer	  semantic	   concept	  based	   information	   retrieval,	   this	   tools	   include	  Relemed	   [10],	   iHop	   [11]	  etc.	  These	   tools	   are	   limited	   to	  abstracts	   and	  miss	   relationships	   that	   are	   stated	   in	   the	   full	  text.	  	  










2.2	  CELL	  LINES	  
2.2.1	  CELL	  LINE	  ONTOLOGY	  (CLO)	  
A	   cell	   line	   is	   a	   colony	   of	   cells	   that	   is	   artificially	   developed	   and	   grown	   under	  controlled	   condition	   [12].	  A	   cell	   line	   is	   typically	  derived	   from	  normal	   tissues	  or	  diseased	  tissues;	   it	   is	   maintained	   as	   both	   permanent	   and	   primary	   cell	   lineages	   depending	   upon	  renewable	  and	  non-­‐renewable	  purposes	  respectively.	  Cell	  lines	  are	  common	  tools	  for	  most	  
in	  vitro	  experiments	  especially	  in	  pharmacology	  to	  understand	  the	  effect	  of	  drugs	  oncertain	  tissues.	   Cell	   lines	   provide	   an	   easy	   platform	   for	   studying	   cellular	   mechanisms	   that	   may	  suggest	  new	  potential	  drug	  targets	  and,	  in	  the	  case	  of	  pathological-­‐derived	  tissue;	  it	  has	  an	  interesting	  application	  in	  the	  evaluation	  of	  therapeutic	  agents	  that	  potentially	  may	  treat	  the	  dysfunction	  [13].	  	  	  





protégé(http://protege.stanford.edu/)	   and	   follows	   the	   OBO	   Foundry	   principles.	   Table	  below	  provides	  a	  tabular	  and	  graphical	  interpretation	  of	  ontologies	  and	  terms	  used	  in	  CLO	  [12].	  
	   	   This	  thesis	  utilizes	  data	  from	  CLO	  [12]	  and	  combines	  it	  with	  other	  catalogues	  like	   Australian	   cellbank	   [30],Breast	   tissue	   [31]	   cell	   line	   ontology	   and	   Leibniz	   institute	  DSMZ-­‐German	  collection	  [32]	  of	  Micro-­‐organisms	  and	  cell	  cultures.	  
	  








2.3	  DRUG	  DATABASES	  
2.3.1	  DRUGBANK	  


















3.1	  DATA	  COLLECTION	  	  	  	  	  	  	  	  	  	  	  	  	  Identification	  and	  collection	  of	  high	  quality	  data	  was	  a	  crucial	  step	  for	  developing	  the	  ontology,	  drug	  dictionary	  and	  the	  corpus.	  The	  datasets	  were	  collected	  from	  both	  public	  and	  commercial	  repositories.	  For	  developing	  the	  drug	  dictionary,	  drug	  cards	  were	  downloaded	  from	  http://www.drugbank.ca/downloads	  of	   the	  DrugBank	   [22]	   database.	   The	  in	  vitro	  PD	  ontology	   construction	   included	  data	   collection	  both	  manually	   and	   from	   repositories.	   The	  manual	  data	  collection	  was	  performed	  for	  drug	  interaction	  type	  and	  method	  classes	  of	  the	  ontology,	   while	   other	   downloads	   includes	   classes	   from	   Gene	   ontology	   [29]	   and	   from	  repositories	  like	  ATCC	  [15],	  HyperCLDB	  [14],	  Cell	  line	  Knowledge	  base	  [14],	  Coriell	  cell	  line	  repository	  [16],	  Bioassay	  ontology	  [17],	  Australian	  cell	  line	  repository	  [30],	  DSMZ	  [32]	  data	  catalogue	  and	  breast	  tissue	  ontology	  [31].	  





synonyms.	  The	  drug	  dictionary	  includes	  over	  6700	  generic	  names	  and	  one	  or	  more	  brand	  names	  or	  drug	  synonyms	  per	  generic	  name.	  
Table	  represents	  few	  term	  of	  the	  drug	  dictionary.	  
DB_ID	   Drug	  generic	  name	   Synonym	   Brand	  names	  DB00091	   Cyclosporine	   Cyclosporine	  A	  	   Restasis,	   Genraf,	   Neoral,	  Sandimmune,	  Sangcya	  DB00115	   Cyanocobalamin	   Vitamin	  B12,	  Cyanocob(III)alamin	   Bedoz,	   Cobex,	   Cobolin-­‐M,	  Crystamine,Cyomin,	  Depinar.	  DB00104	   Octreotide	   Octreodium,	  Octreodita	   Atrigel,	   Longastatin,	  Sandostatin.	  	  DB00165	   Pyridoxine	   Pyridoxol,	  Vitamin	  B6	   Aderoxine,	   Alestrol,	  Becilan,	  Benadon,	  Beesix.	  DB00153	   Ergocalciferol	   Vitamin	  D2	   Condol,	   Calciferol,	   Crtron,	  Buco-­‐D,	   Crystallina,	   D-­‐Arthin,	  D-­‐Tracetten	  Table.	  1	  Drug	  dictionary	  with	  Generic	  names,	  synonyms,	  Brand	  names	  
	  





3.3.1	  DRUG	  INTERACTION	  CLASSES	  
Manual	  investigation	  of	  PD	  related	  studies	  and	  review	  articles	  have	  confirmed	  that	  PD	  drug	  interactions	  fall	  into	  synergistic,	  additive,	  and	  antagonistic	  categories.	  Synergistic	  interaction	   is	   a	   term	   used	   to	   suggest	   a	   drug	   combination	   whose	   effect	   is	   greater	   than	  expected,	  antagonistic	   interaction	  is	  a	  one	  in	  which	  the	  effect	   is	   less	  than	  expected;	  while	  additive	   drug	   interaction	   is	   a	   one	   in	   which	   the	   effect	   is	   just	   what	   is	   expected.The	  terminology	   of	   the	  drug	   interaction	   is	   consistent	   among	  majority	   of	   the	   articles,	   but	   few	  articles	   have	   proposed	   synonyms	   like	   positive,	   supra-­‐additive,	   potentiation	   and	  augmentation	   for	   synergistic	   drug	   interactions;	   negative,	   infra-­‐additive	   or	   sun-­‐additive,	  negative	   synergy	   for	   antagonistic	   drug	   interactions;	   while	   zero	   or	   null	   interaction	   for	  additive	   drug	   interactions	   [23].	   Considering	   the	   drug	   interaction	   types	   and	   different	  naming	  convention	  the	  drug	  interaction	  class	  was	  developed.	  	  	  





3.3.2	  DRUG	  INTERACTION	  ANALYSIS	  	  
Determining	  synergy,	  additivity,	  and	  antagonism	  of	  a	  drug	  combination	  is	  crucial	  for	  detecting	   efficacy,	   toxicity,	   optimal	   doses	   and	   for	   minimizing	   the	   drug	   resistance.	   The	  literature	  presents	  different	  analysis	  methods	   for	  determining	  drug	   interactions,	  many	  of	  these	  methods	  and	  algorithms	  are	  implemented	  in	  the	  form	  of	  software’s.	  For	  the	  ontology	  the	  analysis	  methods	  were	  added	  by	  manual	   inspection	  of	  abstracts	  and	   full	   texts,	   few	  of	  these	   analysis	  methods	   include	   isobolographic	   analysis,	   combination	   index,	  median	   drug	  effect	   analysis,	   Yonetani-­‐Theorell	   plot,	   Chou-­‐Talalay,	   Dixon	   up-­‐down	   method,	   Loewe	  additivity	  etc.	  






3.3.3CELL	  LINE	  CLASS	  
3.3.3.1	  HUMAN	  ORGAN	  SPECIFIC	  
	   Primary	   tissue	   cultures	   are	   a	   valuable	   source	   for	   in	   vitro	   studies,	   however	   due	   to	  scarcity	  of	  suitable	  samples;	  phenotypic	  instability	  and	  unavailability	  of	  fresh	  tissue	  sample	  for	   harvesting	   purposes	   have	   hindered	   the	   widespread	   use	   of	   tissue	   cultures.	   Thus	   to	  overcome	  these	  limitations	  cell	   lines	  models	  have	  been	  proposed.	  Cell	   lines	  are	  known	  to	  be	  the	  back	  bone	  of	  most	  in	  vitro	  experiments;	  literature	  describes	  them	  as	  a	  tool	  or	  model	  for	   analysis	   of	   drug	   metabolism,	   drug	   screening	   and	   toxicity	   studies[26][27].	   The	  knowledge	   of	   different	   cell	   lines	   is	   dispersed	   across	   different	   scientific	   journals;	   many	  academic	  commercial	  repositories	  have	  tried	  to	  provide	  a	  standard	  cell	  line	  catalogue	  but	  have	  failed	  to	  include	  complete	  cell	  line	  coverage.	  Recently	  the	  cell	  line	  ontology	  (CLO)	  [12]	  has	   tried	   to	   capture	   all	   the	   available	   cell	   lines	   and	   successful	   to	   a	   certain	   extent,	   CLO	  includes	  roughly	  around	  	   	  36,000	  cell	  line	  entries	  from	  providers	  like	  Cell	  line	  Knowledge	  Base	   (CLKB)	   [14],	   European	   Coriell	   cell	   line	   ontology	   [16]	   and	   Bioassay	   ontology	   (BAO)	  [17].	  	  





ontology[16]and	  BAO[17]	  provide	  organism,	   tissue	  and	  organ	   information	   for	  all	  cell	   line	  entries,	  if	  the	  organ	  information	  was	  not	  present	  the	  tissue	  was	  mapped	  to	  the	  organ	  using	  tissue	   ontology	   [28]as	   a	   reference.	   The	   human	   organ	   specific	   cell	   line	   class	   with	   organ	  specific	  classes	  was	  thus	  formed	  by	  mapping	  the	  tissue	  information	  to	  organs.	  
Additionally	   the	   ontology	   was	   also	   enriched	   with	   more	   cell	   line	   entries	   from	  Australian	  cell	  line	  repository	  [30],	  breast	  tissue	  cell	  line	  ontology	  [31],	  and	  DSMZ	  [32].	  The	  Australian	   cell	   line	   repository	   is	   a	   national	   facility	   that	   provides	   cell	   lines	   and	   related	  services	   in	  Australia	  and	  other	  parts	  of	  the	  world.	  A	  written	  permission	  was	  obtained	  for	  use	  and	  downloaded	  from	  www.cellbankaustralia.com/Catalogue/default.aspx,	  this	  source	  includes	   around	   34	   cell	   lines.	   The	   Deutsche	   Sammlung	   von	   Mikroorganismen	   und	  Zellkulturen	   -­‐	  DSMZ	   -­‐	   (German	  Collection	  of	  Microorganisms	   and	  Cell	   Cultures)	   [32]	   is	   a	  non-­‐	   profit	   organization	   in	   Germany	   responsible	   for	   preservation	   and	   distribution	   of	  human	  and	  animal	  cell	  lines,	  plant	  cell	  cultures.	  A	  cell	  line	  catalogue	  in	  the	  form	  of	  an	  excel	  file	  was	  downloaded	  and	  includes	  around	  715	  cell	  line	  entries.	  Similarly	  around	  180	  breast	  cell	  lines	  were	  extracted	  from	  the	  breast	  cell	  line	  ontology	  [31].	  After	  combining	  data	  from	  all	   the	   sources	   and	   removal	   of	   possible	   duplicates,	   the	   total	   number	   of	   cell	   lines	   the	  ontology	  has	  is	  around	  32,000.	  (Note:	  The	  data	  supplied	  by	  the	  Coriell	  ontology	  had	  many	  duplicate	  entries)	  





,Pelvis	   ,	   Spleen	   ,	   Prostate	   ,	   Placenta	   ,	   Pharynx	   ,	   Thymus	   ,	   Nervous	   System	   ,	   Connective	  Tissue,	  Thyroid	  ,	  Stomach	  ,	  Fetus	  ,	  Tonsil	  ,	  Vulva	  ,	  Embryo	  ,	  Larynx	  ,	  Fetus	  ,	  Vein	  ,	  Tumor.	  
Organ	  name	   Tissues	  present	   Sample	  Cell	  lines	   Total	  number	  Breast	   Nipple,	  Mammary	  gland	   MCF-­‐7,	  MFM-­‐223	   117	  Skin	   Foreskin,	  Scalp,	  Epidermis	   HFF1,	  Detroit	  532	   2256	  Eye	   Retina,	  Cornea,	  Lens	   ARPE-­‐19,	  HCE-­‐2	   8	  Kidney	   Glomus,	  Cortex.	   Glomotel,	  HK-­‐2	   47	  
Table.	  2	  Represents	  few	  Organ	  with	  their	  tissues,	  sample	  cell	  line	  and	  cell	  line	  count	  
3.3.3.	  2	  ANIMAL	  SPECIFIC	   	  
All	   the	   above	  mentioned	   sources	   also	   provide	   information	   about	   organisms	   other	  than	   human;these	   organisms	   contribute	   to	   the	   animal	   cell	   line	   class.	   Animals	   include	  Camel,	   Cat,	   Fish,	   Chicken,	   Hamster,	   Cusimanse,	   Deer,	   Dog,	   Dolphin,	   Donkey,	   Drosophila,	  Duck,	  Ferret,	  Fox,	  Frog,	  Rat,	  Monkey,	  Goat,	  Goose,	  Guineapig,	  Horse,	  Iguana,	  Insect,	  Lizard,	  Marsupialmouse,	   Mice,	   Minipig,	   Mink,	   Mongoose,	   Mosquito,	   Mouse,	   Muntjac,	   Opossum,	  Orangutang,	  Oryx,	  Sheep,	  Parakeet,	  Pig,	  Quail,	  Rabbit,	  Raccoon,	  Snail,	  and	  Squirrel.	  
Table.	  3	  Showing	  Organism	  corresponding	  cell	  line	  and	  cell	  type	  
	  










	   	  Fig.5	  Data	  collection	  for	  the	  cell	  line	  ontology	  class.	  BA:	  Bioassay	  ontology.	  AT:	  American	  Type	  culture	  collection.	  CL:	  Cell	  line	  database.	  AU:	  Australian	  cellbank	  DS:	  Deutsche	  Sammlung	  von	  Mikroorganismen	  und	  Zellkulturen.	  	  BO:	  breast	  cell	  line	  ontology.	  Cori:	  Coriell	  Cell	  line	  ontology.	  
	  
	  

































Subclasses	  Cell	  death	   Necrotic	  cell	  death	   Oncosis,	  necroptosis	  Cell	  cycle	   Meiotic	  cell	  cycle	   G1	  Phase,	  M	  Phase	  Cell	  aging	   Isotrophic	  growth	   -­‐-­‐	  










DATABASE	  OF	  ANNOTATED	  FULL	  TEXTS	  
	  
4.1	  AUTOMATED	  DOWNLOAD	  OF	  FREE	  FULL	  TEXTS	  FROM	  PUBMED.	  
	   To	   determine	   pharmacodynamically	   relevant	   articles,	   PubMed	   was	   searched	   to	  determine	   literature	   reported	   drug	   combinations.	   Combinations	   of	   keywords	   like	  “synergistic	   drug	   combinations”,	   “synergistic	   drug	   interactions”,	   “additive	   drug	  combinations”,	  “additive	  drug	  interactions”	  etc.	  were	  used.	  These	  keywords	  were	  manually	  investigated	   to	   check	   the	   relevancy	   of	   the	   retrieved	   articles,	   the	   above	   combinations	  retrieved	   huge	   amount	   of	   results	   and	   hence	   the	   manual	   download	   was	   a	   challenge.	   To	  facilitate	  automated	  download	  of	  articles	   from	  PubMed,	  our	   in-­‐house	  PDF	  tool	  developed	  by	  students	  at	  Lang	  Li	  Lab	  was	  used	  to	  download	  articles.	  We	  collected	  around	  502,	  147,	  and	   63	   articles	   published	   in	   last	   5	   years	   that	   were	   pharmacodynamically	   synergistic,	  additive	   and	   antagonisticrepectively.	   Duplicate	   articles	   were	   later	   removed	   and	   a	   total	  of620	  articles	  and	  1270	  abstracts	  for	  which	  full	  text	  articles	  were	  not	  provided	  were	  used.	  
	  We	  discuss	  the	  necessary	  data	  preprocessing	  from	  sections	  4.1.1	  onwards.	  	  
4.1.1	  CONVERSION	  OF	  PDF	  TO	  TEXT	  





limited	  articles	  to	  get	  processed.	  In	  order	  to	  ensure	  overall	  data	  processing,	  programming	  languages	  offer	   conversion	  of	  PDF’s	   to	   formats	   like	  XML	  and	   text.	   In	   this	   study,	  we	  have	  used	   an	   open	   source	   software	   package,	   XPDF	   (http://www.foolabs.com/xpdfv)	   [33],	   to	  convert	   PDF	   files	   to	   text.	   The	   software	   package	   is	   a	   command	   line	   module	   which	   was	  automated	  using	  Perl	  system	  commands	  to	  perform	  batch	  conversion	  of	  PDFs	  to	  text.	  	  	  	  	  	  
	  







4.1.2	  FILTERING	  OF	  RAW	  TEXT	  TO	  TITLES,	  ABSTRACT	  AND	  FULL	  TEXT	  
The	   raw	   text	   files	   generated	   from	   the	  PDF’s	   contained	   additional	   information	   like	  author	  names,	  emails,	   research	   institutes	  and	   finally	  references	   for	  each	  documents.	  This	  information	   is	   not	   important	   and	   was	   excluded	   prior	   to	   data	   annotation	   process	   and	  sections	   like	   titles,	   abstracts	   and	   remaining	   part	   of	   the	   text	   excluding	   references	   was	  extracted.	  	  	  
4.1.3	  SENTENCE	  SEGMENTATION	  AND	  TOKENIZATION	  





The	   raw	   text	   articles	  were	  processed	  using	  Perl	   Lingua::EN::Sentence	  module	   and	  individual	  sentences	  were	  recognized,	  after	  segmentation	  text	  was	  chopped	  into	  individual	  tokens.	   Steps	   until	   sentence	   segmentation	   and	   tokenization	   cover	  most	   of	   the	   data	   pre-­‐processing	  part.	  
4.2	  SENTENCE	  LEVEL	  ANNOTATION	  
The	  following	  section	  covers	  the	  procedure	  for	  sentence	  level	  annotations	  	  
4.2.1	  NAMED	  ENTITY	  RECOGNITION	  AND	  ANNOTATION	  WITH	  TERMS	  OF	  ONTOLOGY	  	  
Named	  entity	  recognition	  (NER)	   is	  a	  step	   in	   information	  retrieval	   that	   is	  assists	   in	  locating	   and	   classifying	   entities	   into	   desired	   categories.	   In	   the	   presented	   study,	   entities	  were	   categorized	   into	   drug,	   drug	   interaction,	   cell	   phenotypes,	   and	   cell	   lines	   types.	   The	  identified	  entities	  were	  annotated	  (marked-­‐up)	  with	  specific	  XML	  tags.	  	  The	  NER	  algorithm	  was	   build	   using	   hashes	   and	   necessary	   regular	   expression;	   it	   can	   accurately	   identify	   and	  annotate	  entities	  along	  with	  their	  variants.	  	  
Category	   Sample	  entity	   Total	  number	  identified	  Interaction	   Additive,	  synergistic	   2784	  Cell	  lines	   Breast	  (MCF-­‐7),	  Rat(AR42J)	   5399	  Phenotypes	   Cell	  death,	  proliferation	  	   3679	  





4.2.2	   NAMED	   ENTITY	   RECOGNITION	   AND	   ANNOTATION	   WITH	   TERMS	   OF	   DRUG	  
DICTIONARY	  













DEVELOPMENT	  OF	  A	  SEMANTICALLY	  ANNOTATED	  IN	  VITRO	  PD	  CORPUS	  
FOR	  TEXT	  MINING	  	  Text	   mining	   systems	   have	   become	   indispensable	   for	   biomedical	   research,	   while	  Natural	   Language	   processing	   (NLP)	   has	   raised	   the	   TM	   accuracy	   and	   performance.	   	   NLP	  techniques	  are	  relatively	  domain	  portable	  but	  lack	  of	  a	  domain	  specific	  reference	  material	  has	  always	  been	  a	  major	  issue	  for	  validation	  of	  the	  TM	  accuracy.	  Most	  reference	  materials	  are	  available	   in	   the	   form	  of	  annotated	  corpuses,	  which	  are	  expert	  curated	  and	  serve	  as	  a	  gold	  standard	  for	  evaluation.	  Different	  domain	  specific	  corpuses	  like	  the	  GENIA	  [35]	  corpus	  have	  been	  suggested	  in	  the	  past	  and	  recognized	  as	  highly	  quality	  reference	  material.	  In	  this	  chapter	  we	   try	   to	   take	   advantage	   of	   the	   in	   vitro	   PD	   ontology	   and	   the	   drug	   dictionary	   to	  propose	  a	  semantically	  annotated	  corpus	  for	  PD	  TM	  based	  upon	  the	  GENIA	  guidelines.	  	  	  	  	  	  






5.1.1	  CORPUS	  ANNOTATIONS	  	  
	   The	   corpus	   annotations	   are	   based	   upon	   the	   domain	   ontology	   and	   dictionary.	   The	  development	   of	   the	   ontology	   and	   the	  dictionary	   is	   already	  mentioned	   in	   chapters	   3.	   The	  corpus	   is	   enriched	  with	   important	   concepts	  and	   classes	   that	   include	  drug	  names,	  human	  and	  animal	  cell	  lines,	  cell	  phenotypes,	  drug	  interaction	  type,	  drug	  concentration	  (numbers),	  and	  DDI	  identification	  methods.	  
 Drug	  names	  where	  extracted	  from	  drug	  cards	  of	  the	  DrugBank[22]	  3.0	  release.	  The	  drug	  dictionary	   is	   based	  upon	   this	   release	   and	   annotates	  most	  drug	  names	   in	   the	  corpus.	  
 Cell	   lines	   cover	   both	   human	   and	   animal	   cell	   lines.	   The	   human	   cell	   lines	   are	  categorized	   organ	   wise	   and	   include	   48	   organs,	   while	   the	   animal	   cell	   lines	   are	  categorized	  based	  upon	  animal	  names	  and	  covers	  animal	  types.	  
 Cell	   phenotypes	   include	   classes	   like	   cell	   death,	   cell	   growth,	   cell	   division,	   cell	  proliferation,	  and	  cell	  aging.	  The	  annotation	  schema	  is	  based	  upon	  above	  mentioned	  classes	  and	  their	  respective	  subclasses.	  	  
 	  Drug	   Interactions	   include	   synergistic,	   additive,	   and	   antagonistic	   drug	   interactions	  with	   their	   synonyms	   like	   supra-­‐additive,	   null	   interaction	   and	   infra-­‐additive	  respectively.	  	  
 Drug	  concentration	  includes	  drug	  dosages	  and	  concentration.	  
 Units	  includes	  different	  units	  used	  to	  measure	  drug	  concentrations.	  	  





NOTE:	   All	   the	   above	   terms	   were	   stemmed	   to	   their	   basic	   form	   using	   Perl	   Lingua::Stem	  module	   (Downloaded	   from	   the	   CPAN	   repository)	   before	   the	   entity	   recognition	   and	  annotation	  procedure.	  	  
5.1.2	  PD	  TAGGER	  
The	  in	  vitro	  PD	  abstracts	  were	  annotated	  using	  a	  Perl	  implemented	  PD	  tagger.	  The	  tagger	  tagged	  the	  abstract	  entities	  following	  entries	  in	  the	  drug	  dictionary	  and	  the	  domain	  ontology.	   The	   tagging	   work	   flow	   can	   be	   divided	   into	   3	   steps:	   1)	   Sentence	   boundary	  detection	  achieved	  using	  Lingua::En::Sentence	  module.	  This	  module	  is	  written	  in	  Perl	  and	  performs	  sentence	  segmentation	  with	  a	  higher	  accuracy.	  2)	  Tokenization	  was	  based	  upon	  simple	   white	   space	   tokenization	   approach,	   which	   allowed	   separation	   of	   words	   into	  individual	  units.	  3)	  Named	  Entity	  Recognition	  (NER)	  was	  the	  step	  where	  the	  actual	  entity	  markup	  was	  performed.	  The	  mark	  up	  algorithm	  uses	  a	  set	  of	  hashes	  and	  regular	  expression	  to	  tag	  tokenized	  entities.	  	  	  	  
The	  PD	   tagger	   tags	   the	   following	   entities	   from	   the	   domain	   ontology	   and	   the	   drug	  dictionary:	  1)	  Drug	  names.	  2)	  Drug	  interactions.	  The	  drug	  interactions	  include	  synergistic,	  additive,	  and	  antagonistic	  drug	  interactions.	  3)	  Cell	  lines.	  For	  example	  breast	  cell	  lines	  like	  MCF-­‐7,	   HCC1569,	   MCF10A,	   MDA-­‐kb2	   etc.	   4)	   Cell	   phenotypes.	   For	   example	   necrosis,	  apoptosis,	   cornification,	   pyroptosis	   etc.	   	   5)	   Number.	   To	   represent	   drug	   concentration	   or	  cell	  line	  sample	  size.	  6)	  Methods.	  For	  example	  Isobolographic	  analysis,	  combination	  index,	  median	  drug	  effect	  analysis,	  Yonetani-­‐Theorell	  plot,	  Chou-­‐Talalay	  etc.	  





capable	   of	   performing	   part-­‐of-­‐speech	   tagging	   based	   upon	   Lingua::EN::Tagger	  (http://search.cpan.org/~acoburn/Lingua-­‐EN-­‐Tagger-­‐0.23/Tagger.pm)	   downloaded	   from	  CPAN	  repository.	  	  
5.1.3	  SENTENCE	  LEVEL	  ANNOTATIONS	  
Sentence	  level	  annotation	  is	  the	  next	  level	  of	  annotations	  performed	  after	  term	  level	  annotations.	  Sentence	  level	  annotation	  is	  a	  manual	  process	  and	  classifies	  drug	  interaction	  sentences	  into	  true	  DDI,	  ambiguous	  DDI,	  and	  non	  DDI.	  	  
 True	   DDI	   Sentences	   (TDDIS):	   Two	   drug	   names	   are	   in	   the	   sentence	   stating	  clear	  interaction	  and	  its	  type.	  (Synergistic,	  additive	  and	  antagonistic).	  
 Non	  DDI	  Sentences	  (NDDIS):	  Two	  drug	  names	  are	  in	  the	  sentence	  with	  clear	  negation	  suggesting	  that	  drugs	  do	  not	  interact.	  	  
 Ambiguous	  DDI	   Sentences	   (ADDIS):	  One	   drug	   is	   absent	   in	   the	   sentence,	   but	  DDI	   could	   be	   inferred	   from	   the	   context.	   	   A	   clear	   interaction	   statement	   is	  essential.	  	  
5.2	  GENIA	  FORMAT	  





	  Fig.	  7	  Configuration	  of	  PD	  corpus	  	  
	  	   Fig.	  8Browser	  based	  display	  of	  the	  corpus	  
	  
5.3	  CONCLUSION	  
The	   in	   vitro	   PD	   corpus	   is	   highly	   enriched	   with	   PD	   annotations	   it	   also	   includes	  sentence	  boundaries,	   term	  boundaries,	   term	  classification	   and	   sentence	   level	   annotation.	  We	  hope	  to	  that	  researchers	  utilize	  this	  resource	  is	  their	  research	  and	  expect	  to	  get	  their	  valuable	  feedback	  for	  further	  improvement	  of	  the	  corpus.	  






ACCESSING	  THE	  WEB	  INTERFACE	  
	   The	   development	   of	   the	   in	   vitro	   PD	   miner	   was	   powered	   by	   providing	   a	   user	  interface;	   the	  user	   interface	  was	  developed	  using	  HTML,	   CSS,	   JavaScript,	   and	  PHP	   and	   is	  available	   at	   http://rweb.biostat.iupui.edu/pdcorpus/retrieval/index.html.	   The	   tool	   is	  capable	   of	   retrieving	   articles	   and	   extracting	   domain	   sentences	   from	   both	   full	   text	   and	  abstracts.	   The	   following	   chapter	   provides	   details	   about	   access	   and	   function	   of	   different	  options/tabs	  on	  the	  interface.	  	  
6.1	  HOME	  





user	   can	   provide	   drug	   names	   in	   the	   form	   of	   keywords,	  while	   drug	   interaction	   type,	   cell	  lines	  and	  cell	  phenotypes	  in	  the	  form	  of	  categories.	  As	  mentioned	  in	  last	  chapters	  this	  TM	  system	   is	   powered	   by	   drug	   dictionary	   and	   hence	   drug	   names	   can	   be	   searched	   in	  combination	  with	  the	  brand	  names	  and	  synonyms	  from	  the	  dictionary.	  	  	  
6.2	  BROWSE	  





is	  developed	  using	  JavaScript,	  HTML	  and	  CSS,	  and	  can	  be	  accessed	  by	  clicking	  the	  browse	  button	  http://rweb.biostat.iupui.edu/pdcorpus/retrieval/demo/Hello.html	  
6.3	  SEARCH	  






	  Fig.	  12	  Online	  view	  of	  the	  annotated	  corpus	  	  	   Fig.	   13	   provides	   an	   overview	   of	   the	   semantically	   annotated	   corpus;	   the	   data	   is	  annotated	   to	   XML	   tags	   following	   the	   PD	   tagger	   as	   explained	   in	   chapter	   5.	   Annotations	  include	  drug	  names,	  DDI,	  cell	  lines,	  cell	  phenotypes,	  numbers	  (to	  represents	  concentration)	  and	   data	   analysis	   technique	   used.	   Apart	   from	   term	   level	   annotation	   the	   current	   corpus	  release	   also	   includes	   sentence	   level	   annotations	   in	   the	   form	   of	   true	   DDI,	   non-­‐DDI	   and	  ambiguous	  DDI.	  Every	  annotation	  is	  visually	  highlighted	  using	  CSS.	  The	  corpus	  is	  available	  at	  http://rweb.biostat.iupui.edu/pdcorpus/retrieval/test.xml.	  	  	  









7.1.1	  PHARMACODYNAMICS	  MINER	  DATABASE	  OVERVIEW	  We	   have	   developed	   Pharmacodynamics	   Miner,	   a	   text	   mining	   tool	   capable	   of	  retrieving	  PD	  articles	  and	  extracting	  PD	  related	  facts	  (sentences)	  from	  database	  of	  articles.	  	  Splitting	   articles	   into	   sentences	  develops	  PD	  miner,	   and	   sentences	   tokenized	   into	  words.	  Each	   word	   is	   then	   annotated	   using	   the	   eXtensibleMarkupLanguage	   (XML)	   following	   the	  entries	   from	   the	   drug	   dictionary	   and	   ontology.	   The	   markup	   words	   are	   then	   indexed	   to	  facilitate	  rapid	  search	  and	  retrieval	  of	  sentences	  mentioning	  the	  desired	  terms.	  PD	  Miner	  uses	  a	  database	  of	  full	  text	  articles	  and	  abstracts;	  table	  A	  provides	  a	  good	  description	  of	  the	  PD	  database.	  
#	  Full	  text	  articles	   630	  #	  Abstracts	   1732	  #	  Drug	  terms	   12328	  #	  Cell	  lines	   5617	  #	  Cell	  Phenotypes	   3679	  #	  Interactions	   2784	  







Fig.	  13Shows	  the	  PD	  Miner	  pipeline	  for	  document	  retrieval	  and	  sentence	  extraction	  
	  
7.1.2	  EVALUATION	  OF	  PD	  MINER	  






Fig.	  15	  provides	  a	  description	  of	  the	  evaluation	  step.	  Table	  8	  is	  a	  general	  overview	  of	  DDI	  sentences	  retrieved	  by	  human	  experts	  and	  the	  system.	  

















Recall	  of	  PD	  
Miner	  
	  
Precision	  of	  PD	  
Miner	  
19513066	   11	   9	   18	   81%	   50%	  21474657	   11	   9	   12	   81%	   75%	  18594016	   4	   2	   5	   50%	   40%	  21646547	   2	   2	   2	   100%	   100%	  20576088	   8	   5	   21	   62.5%	   23.8%	  Total	   36	   27	   58	   75%	   46.55%	  





7.1.2.1	  ERROR	  ANALYSIS	  




Missed	  drug-­‐drug	  interaction	  sentences	  





The	   retrieval	   algorithm	   is	   implemented	   in	   such	   a	   way	   that	   it	   extracts	   sentences	  based	   upon	   co-­‐occurrences	   of	   drug	   interaction	   type	   and	   drug	   names.	   The	   sentence	  “Importantly,	   combination	   treatment	   with	   doxorubicin	   resulted	   in	   synergistic	   growth	  inhibition	  in	  all	  cell	  lines	  and	  blocked	  the	  migration	  and	  invasion	  of	  the	  highly	  metastatic,	  triple-­‐negative	  MDA-­‐MB-­‐231	  cell	   line.”	  (PubMed:19513066),	  doesn’t	  mention	  the	  name	  of	  the	  second	  drug	  thus	  system	  fails	  to	  identify	  the	  sentence	  as	  DDI.	  Combination	  index	  (CI)	  is	  good	  measure	  to	  determine	  additivity,	  synergism	  and	  antagonism	  of	  a	  drug	  combination,	  in	  the	  sentence	  “The	  CI	  values	  calculated	  for	  50%	  inhibition	  of	  these	  cells	  were	  0.05	  and	  0.04,	  respectively,	  indicating	  very	  strong	  synergy”,	  only	  the	  CI	  value	  and	  the	  type	  of	  interaction	  is	  mentioned	  but	  the	  sentence	  lacks	  both	  interacting	  drugs	  and	  hence	  is	  not	  recognized	  by	  the	  system.	  Similarly,	  almost	  all	  the	  remaining	  sentences	  miss	  either	  one	  or	  both	  drug	  names,	  in	  order	  to	  extract	  and	  understand	  such	  DDI,	  context	  of	  sentences	  that	  are	  above	  or	  below	  is	   essential.	   To	   extract	   these	   types	  of	   sentences	   complex	  NLP	   system	  and	  algorithms	  are	  required.	  	  
7.2	  PD	  MINER	  IS	  CAPABLE	  OF	  CATEGORICAL	  SEARCHES	  





Miner	  for	  drug	  interaction	  using	  cell	  death	  and	  brain	  cell	  line	  as	  the	  categories.	  As	  seen	  in	  fig.3	  the	  system	  had	  identified	  apoptosis	  as	  a	  member	  of	  the	  cell	  death	  class	  and	  “sk-­‐n-­‐dz”	  and	   “sh-­‐sy5y”	   as	  member	  of	   the	  brain	   cell	   line	   class.	  This	   example	   strongly	   supports	   the	  idea	  that	  an	  information	  extraction	  system	  that	  considers	  word	  semantics	  for	  a	  query	  can	  greatly	  increase	  both	  precision	  and	  recall	  of	  the	  retrieval.	  	  	  
	  Fig.15	  Categorical	  search	  with	  cell	  death	  and	  brain	  cell	  line	  
	  
7.3	  COMPREHENSIVE	  CELL	  LINE	  COVERAGE	  	  





with	   cell	   line	   entities	   from	  DSMZ,	  ATCC,	  Coriell	  Ontology,	   breast	   tissue	   cell	   line	  ontology	  etc.	  The	  retrieved	  information	  for	  a	  search	   is	  not	   limited	  to	  cell	   line	  but	  also	   includes	  the	  cell	   type,	   organism	   from	  which	   the	   cell	   line	   is	   extracted	   and	   the	   cell	   line	   supplier.	   Fig.	   4	  describes	  situation	  where	  a	  user	  queries	   the	  system	  to	  retrieve	  all	  MCF	  based	  breast	  cell	  lines.	  As	  seen	  in	  the	  figure	  along	  with	  the	  cell	   line	  name	  information	  about	  the	  organism,	  tissue	  source	  and	  repository	  is	  also	  provided.	  
	  Fig.	  16	  Cell	  line	  search	  	  
	  
	  
7.4	  CORPUS	  AND	  ONTOLOGY	  





studies,	   it	   includes	   both	   term	   and	   sentence	   level	   annotation.	   Most	   step	   of	   the	   corpus	  development	   is	  manual.	  The	   in	   vitro	   PD	  ontology	   is	   an	  effort	   to	   standardize	  PD	  concepts	  and	   knowledge.	   The	   ontology	   was	   developed	   using	   protégé	   and	   includes	   classes	   and	  multiple	   subclasses.	   Ontology	   development	   involved	   both	   manual	   and	   repository	   based	  data	   collection.	  Considering	   the	   categorical	   search	   results	   an	  ontology	  based	   information	  retrieval	  system	  is	  crucial	  for	  having	  a	  wide	  coverage	  of	  terms	  in	  the	  searches.	  	  	  








8.1	  ACCOMPLISHMENTS	  	  
	   We	   have	   developed	   PD	   Miner	   a	   system	   that	   is	   capable	   of	   retrieving	   information	  from	   full	   text	   PD	   articles.	   As	   of	   January	   2013,	   the	   database	   includes	   full	   text	   articles	  published	   during	   the	   last	   five	   years.	   The	   semantic	   categories	   and	   text	   markup	   have	  introduced	  a	  new	  and	  a	  meaning	  full	  way	  to	  query	  the	  biological	  literature.	  The	  evaluation	  of	  the	  system	  has	  revealed	  that	  presence	  of	  full	  text	  is	  important	  for	  developing	  a	  new	  bio	  retrieval	   system	   that	   can	   present	   a	  wide	   number	   of	   biological	   facts	   and	   concepts	  with	   a	  high	   recall	   and	   a	   satisfying	   precision,	   which	   ultimately	   could	   help	   domain	   curators	   and	  researchers.	   For	   researcher	   and	   curators	   presence	   of	   such	   a	   system	   offers	   a	   great	  advantage	  over	  manual	  skimming	  of	  the	  text.	  PD	  Miner	  is	  an	  important	  ontology	  based	  full	  text	   search	   system,	   and	   offer	   great	   advantages	   even	  with	   low	   precision.	   The	   current	   PD	  Miner	  algorithm	  can	  be	  improved	  to	  achieve	  a	  higher	  precision.	  	  





	   The	  development	  of	  the	  ontology	  is	  also	  an	  important	  contribution	  and	  encourages	  domain	   expert	   to	   use	   the	   ontology	   as	   a	   means	   of	   a	   central	   knowledge	   representation.	  Classes	  like	  drug	  interactions,	  cell	  lines	  and	  cellular	  phenotypes	  are	  primary	  basis	  of	  an	  in	  
vitro	   PD	   experiment	   they	   cover	   almost	   all	   term	   semantics	   and	   class	   definitions.	   The	  ontology	  can	  be	  further	  edited	  or	  reused	  to	  develop	  any	  other	  domain	  ontology.	  Along	  with	  the	   ontology	   the	   drug	   dictionary	   has	   also	   played	   an	   important	   role	   in	   presenting	   term	  semantics	  and	  overcoming	  different	  drug	  conventions.	   It	   is	  apparent	   from	  the	  result	   that	  both	  the	  drug	  dictionary	  and	  the	  ontology	  have	  improved	  both	  the	  precision	  and	  recall	  of	  the	  TM	  system.	  	  
	   The	  presented	  corpus	  is	  highly	  enriched	  with	  term	  level	  annotations	  like	  cell	  lines,	  drug	  names,	  cell	  phenotypes,	  DDI	  types,	  drug	  concentrations	  and	  POS	  based	  annotations,	  it	  also	   cover	   sentence	   annotations	   and	   divide	   the	   DDI	   into	   DDI,	   Non-­‐DDI	   and	   ambiguous	  types.	  Such	  annotations	  are	  highly	  significant	  will	  performing	  NLP	  based	  operations	   they	  provide	   a	   good	   control	   for	   entity	   recognition	   and	   extraction.	   Many	   NLP	   studies	   are	  performed	  on	  corpuses,	  the	  accuracy	  of	  these	  NLP	  algorithms	  are	  determined	  based	  upon	  their	   ability	   to	   identify	   and	   extract	   facts	   and	   relations.	   Since	   the	   presented	   corpus	   is	  manually	  annotated	  it	  can	  serve	  as	  an	  important	  gold	  standard	  encouraging	  more	  NLP	  and	  TM	  based	  studies	  on	  the	  PD	  domain.	  






	   The	  text	  mining	  system	  is	  limited	  in	  with	  respect	  to	  the	  coverage	  of	  full	  text	  article	  and	   concepts	   from	   the	   ontology.	   The	   current	   database	   covers	   around	   630	   free	   full	   text	  articles,	  paid	  and	  subscribed	  journals	  are	  not	  included	  in	  the	  current	  database.	  The	  articles	  are	  also	  limited	  to	  last	  5	  years	  as	  the	  PDF	  download	  tool	  at	  Lang	  Li	  lab	  is	  still	  at	  infancy,	  for	  now	  it	  can	  download	  articles	  from	  limited	  journals.	  The	  ontology	  covers	  concepts	  only	  for	  the	   in	  vitro	  PD	  experiments;	   in	  vivo	   concepts	  are	  not	   included	   in	   the	  current	  release.	  Cell	  line	  classes	  of	  the	  ontology	  still	  miss	  some	  cell	   lines	  and	  did	  not	  get	  annotated	  during	  the	  NER	   process.	   	   Some	   cell	   lines	   are	   represented	   by	   number	   and	   not	   by	   alphabets	   or	  alphanumeric	   characters.	   For	   example	   the	   human	   lymphoblast	   cell	   line	   ‘36’	   is	   falsely	  identified	   as	   concentration	   (number)	   than	   as	   cell	   lines.	   Fortunately	   the	   retrieved	   results	  from	  PD	  Miner	  are	  in	  the	  form	  of	  sentences	  highlighting	  important	  concepts	  thus	  a	  domain	  expert	  from	  the	  context	  of	  the	  sentence	  can	  easily	  identify	  and	  discard	  such	  irrelevant	  hits.	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